Main pathogen
Mycobacterium Tuberculosis
Mycobacterium Tuberculosis
Transmission of TB
Aerosol
Risk factors
Treatment of Active TB
2. 2 drugs for further 4 months: RI.
RIPE
Rifampicin, Isoniazid, Pyrazinamide, Ethambutol.
Treatment of Latent TB
Immune Response to MTB
CMI
Cell-Mediated Th1-biased immunity: Key to successful anti-tuberculosis immune response.
Defective CMI
E.g. children, HIV affected persons, patients taking anti-TNF-a drugs.
Increased risk of TB.
Why is MTB ideally suited to infect & survive within humans?
It is an ancient human pathogen that has co-evolved with modern homosapiens.
Symptoms of TB
Signs of TB
Upper zone crackles.
Tests for TB
Sputum culture, PCR, Ziehl Neelson, CXR, Tuberculin skin test, Bronchoscopy, AAFB, GIT.
CXR of Patient with MTB
Caseous necrosis, fibrosis and calcification in upper lobes, consolidation.
Side effects of Rifampicin
Enzyme induction => orange bodily fluids.
Increased liver metabolism.
Side effects of Izoniazid
Neuropathy, hepatitis
Side effects of Pyrazinamide
Hepatitis, vomiting, hyperuricaemia
Side effects of Ethambutol
Colour blindness
Type of hypersensitivity
Type IV (delayed)
Other causative organisms
Mycobacterium Bovis
Immunity
T-Cell response to organism enhances macrophage ability to kill mycobacteria.
Hypersensitivity
T-Cell response causes granulomatous inflammation, tissue necrosis & scarring.
Primary TB Pathology
Inhaled organism phagocytosed & carried to hilar lymph nodes. Immune activation (few weeks) leads to granulomatous response in nodes & lungs => leads to killing.